Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
3.130
-0.050 (-1.57%)
Aug 13, 2025, 4:00 PM - Market closed
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $84.74 million as of August 14, 2025. Its market cap has decreased by -76.68% in one year.
Market Cap
84.74M
Enterprise Value
-38.51M
1-Year Change
-76.68%
Ranking
Category
Stock Price
$3.13
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has decreased from $528.69M to $84.74M, a decrease of -83.97%. That is a compound annual growth rate of -69.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 84.74M | -25.72% |
| Dec 31, 2024 | 114.08M | -78.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| Novartis AG | 234.72B |
| AstraZeneca | 232.33B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |